General Proximity is a seed stage biotechnology platform company founded in 2019 to pioneer the next generation of induced proximity medicines for undruggable targets.
Date |
Amount |
Type |
Investors |
Valuation |
---|---|---|---|---|
01/03/25 | $16,000,000 |
age1 Ben Mann Felicis Ventures ![]() Jeff Dean Modi Ventures Uri Lopatin Wilson Sonsini Investments | undisclosed |